HCID 21401585、化合物 → 7-{N-[4-hydroxy-5-(4-fluorophenoxy)trans-2-pentenyl]methanesulfonamido}hept-5-ynoic acid
反応式
C(OC(COC1C=CC(F)=CC=1)CCCNS(C)(=O)=O)(=O)C.C(OC(COC1C=CC(F)=CC=1)/C=C/CNS(C)(=O)=O)(=O)C.C([O:48][CH:49]([CH2:68][O:69][C:70]1[CH:75]=[CH:74][C:73]([F:76])=[CH:72][CH:71]=1)/[CH:50]=[CH:51]/[CH2:52][N:53]([CH2:58][C:59]#[C:60][CH2:61][CH2:62][CH2:63][C:64]([O:66]C)=[O:65])[S:54]([CH3:57])(=[O:56])=[O:55])(=O)C>>[OH:48][CH:49]([CH2:68][O:69][C:70]1[CH:71]=[CH:72][C:73]([F:76])=[CH:74][CH:75]=1)/[CH:50]=[CH:51]/[CH2:52][N:53]([CH2:58][C:59]#[C:60][CH2:61][CH2:62][CH2:63][C:64]([OH:66])=[O:65])[S:54]([CH3:57])(=[O:56])=[O:55]参加物
4
反応物 3
生成物 1
実験手順
This compound is prepared by the procedure described in Example 2, Step I, except that the N-[4 -acetoxy-5-(4-fluorophenoxy)pentyl]methanesulfonamide is replaced by an equimolar amount of N-[4-acetoxy-5-(4 -fluorophenoxy)trans-2-pentenyl]methanesulfonamide (Example 6, Step G). This product is thus methyl 7-{N-[4-acetoxy-5-(4-fluorophenoxy)trans-2-pentenyl] -methanesulfonamido}hept-5-ynoate. The subsequent hydrolysis is carried out as described in Example 2, Step J and affords 7-{N-[4-hydroxy-5-(4-fluorophenoxy)trans-2 -pentenyl]methanesulfonamido}hept-5-ynoic acid. The hydrogenation is carried out by the procedure described in Example 3 and affords the subject compound.
後処理
- customThis compound is prepared by the procedure
- customThe subsequent hydrolysis
出典と根拠
- ORDレコード
- ord-3237767bfca1433b99718181a46a0c10
- 出典データセット
- uspto-grants-1976_11
- 特許番号
- US03991106
反応ノート
読み込み中…